Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

408
active users

med-mastodon.com: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.8

#OncTwitter

0 posts0 participants0 posts today
Public
Johnathan Ebben MD, PhD

It's here! featuring latest management strategies for NET, including hypermutated NET. Can't wait to learn 📚!
---
RT @jessrzanotti
@TumorBoardTues 1/15
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L …
twitter.com/jessrzanotti/statu

TwitterJéssica Zanotti on Twitter“@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter 46yo 👩🏻 asymptomatic no comorb 🌀Screening abd US: liver nodules + pancreatic mass (body/tail) 🔬Liver bx + NET G2 Ki67 12% 🩻PET-Ga + uptake in pancreas & liver (SUVs>20) 💉1L: Lanreotide SC - DP liver after 1y (⬆️volume) 🤨What 2L tx?”
Public
TumorBoardTuesday

📢 Join our 🇧🇷 Brazilian-led #TumorBoardTuesday!!

🥼@RachelRiechelm2 @jessrzanotti teach us treating hypermutation induced in NET #PancreaticCancer
👇🏽

📱Weigh in
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👩🏻‍⚕️tag peers
@MPishvaian @JohnEbbenMDPhD
#MedTwitter #WomenInOncology
---
RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass …
twitter.com/jessrzanotti/statu

TwitterJéssica Zanotti on Twitter“@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter 46yo 👩🏻 asymptomatic no comorb 🌀Screening abd US: liver nodules + pancreatic mass (body/tail) 🔬Liver bx + NET G2 Ki67 12% 🩻PET-Ga + uptake in pancreas & liver (SUVs>20) 💉1L: Lanreotide SC - DP liver after 1y (⬆️volume) 🤨What 2L tx?”
Public
TumorBoardTuesday

📢 #TumorBoardTuesday is here!!

🥼@LealTiciana @JennyCarlisleMD teach us about treating exon 20 insertion in #NSCLC

👇🏽👇🏽

📱Weigh in your answers
🧾Bring receipts
🙋Ask Q’s
📊check the polls
🔁RT
👩🏻‍⚕️tag peers👩🏻‍⚕️
@MPishvaian @JohnEbbenMDPhD
#MedTwitter #LungCancer
---
RT @JennyCarlisleMD
@TumorBoardTues @LealTiciana 1/21 #TumorBoardTuesday #LungCancer #OncTwitter

47yo 👨🏽‍💼🚭
No significant PMHx
Incidental 📏 2.8cm cavitary RLL nodule …
twitter.com/JennyCarlisleMD/st

TwitterJennifer Carlisle on Twitter“@TumorBoardTues @LealTiciana 1/21 #TumorBoardTuesday #LungCancer #OncTwitter 47yo 👨🏽‍💼🚭 No significant PMHx Incidental 📏 2.8cm cavitary RLL nodule on coronary calcium scan in 2020 FDG 💥on PET with hilar LN 💥 🫁🎥 Mediastinoscopy shows adenocarcinoma, + subcarinal LN (stage IIIA) 🤨 How would you treat?”
Public
Johnathan Ebben MD, PhD

It's here! Time for . This week, @marijasullivan & @JenniferLitton explore unique considerations for younger pts w BRCA2+ . @BRCAUmbrella @LivingBeyondBC @BreastCaupdates
---
RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 …
twitter.com/marijasullivan/sta

TwitterMarija Sullivan on Twitter“@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter 32 yo 👩🏽 4 months post-partum 🚫comorbidities FHx paternal uncle with #PanCan 🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30% Clinically node+; FNA confirms LN involvement 🚫 e/o metastatic dz 🤔Do all EXCEPT?”
Public
TumorBoardTuesday

📢 FINALLY #TumorBoardTuesday is here!!

🥼@JenniferLitton @marijasullivan teach us treating early stage BRCA+ #BreastCancer in the younger patient

👇🏽👇🏽

📱Weigh in your answers
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👩🏻‍⚕️tag peers👩🏼‍⚕️
@MPishvaian @JohnEbbenMDPhD
#MedTwitter
---
RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx pat…
twitter.com/marijasullivan/sta

TwitterMarija Sullivan on Twitter“@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter 32 yo 👩🏽 4 months post-partum 🚫comorbidities FHx paternal uncle with #PanCan 🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30% Clinically node+; FNA confirms LN involvement 🚫 e/o metastatic dz 🤔Do all EXCEPT?”
Public
Johnathan Ebben MD, PhD

⏰Starting NOW! Join as @drfrankiejs & @tompowles1 as we discuss 1L and neoadjuvant approaches in ! @Uromigos @EAU_YAUrotheli @UroDocAsh
---
RT @BartsECMC
@TumorBoardTues 1/15
75yo👴🏽
HTN: Amlodipine
T2DM: Metformin, Insulin
6 mo: haematuria & weight loss
CTCAP: thickened bladder wall with L side hydronephrosis & borderline paraaortic LNS. No distant mets
…
twitter.com/BartsECMC/status/1

Public
TumorBoardTuesday

📢This week’s #TumorBoardTuesday is here!!

🥼@tompowles1 @drfrankiejs teach us about neoadjuvant #BladderCancer
👇🏽 Join us!👇🏽

📱Weigh in what you’d do
🧾Bring receipts
🙋Ask YOUR Q’s
📊check polls
🔁RT
🧑🏽‍⚕️tag peers👨🏼‍⚕️
🏆Earn 𝓕𝓡𝓔𝓔 CME
@MPishvaian @JohnEbbenMDPhD
#MedTwitter
---
RT @BartsECMC
@TumorBoardTues 1/15 #TumorBoardTuesday #BladderCancer #OncTwitter
75yo👴🏽
HTN: Amlodipine
T2DM: Metformin, Insulin
6 mo: haematuria & weight loss
CT…
twitter.com/BartsECMC/status/1

Public
Johnathan Ebben MD, PhD

Here's the thread- join in as @RischZack & @shafiarahman_ discuss the latest data around anti-EGFR tx strategies in !
---
RT @RischZack
@TumorBoardTues @MPishvaian @JohnEbbenMDPhD @CCAlliance 1/22 @shafiarahman_

62 yo 👨🏼‍🦳 asymptomatic
🔦 Screening colonoscopy - sigmoid mass
🔬Biopsy + for pMMR/MSS adenocarcinoma
🩻Staging CT + for unresectable liver mets

🤨…
twitter.com/RischZack/status/1

TwitterTweet / Twitter
ExploreLive feeds
About